Mohieldin Ashraf M, Spencer Madison, Bernal Carter, Fadol Wala B, Gupta Ankan, Thirugnanam Karthikeyan, Delahunty Claire, Nunez Francisco, Pan Amy Y, Brandow Amanda M, Palecek Sean P, Rarick Kevin R, Ramchandran Ramani, Zennadi Rahima, Yates John, Nauli Surya M
College of Graduate Studies, Master Program of Pharmaceutical Science, California Northstate University, Elk Grove, California 95757, United States.
Department of Basic Science, College of Medicine, California Northstate University, Elk Grove, California 95757, United States.
J Proteome Res. 2025 Jun 6;24(6):2981-2995. doi: 10.1021/acs.jproteome.5c00168. Epub 2025 May 15.
Sickle cell disease (SCD) is an inherited hemoglobinopathy characterized by sickle-shaped red blood cells (RBCs). Primary cilia are mechanosensory organelles and are projected in the lumen of blood vessels to detect blood flow. We previously reported that interaction between microvasculature endothelial cells and sickled RBCs resulted in altered blood flow that can elevate reactive oxygen species, leading to increased deciliation in SCD patients. However, the impact of deciliation mediated by sickled RBCs in the context of the ciliary protein profiles remains unclear. Here, we investigated cell-cilia stability under different physiological shear-stress magnitudes and examined cilia protein profiles in SCD, utilizing mouse models and human participants. Our results demonstrate that subjecting endothelial cilia to sickled RBCs at 5.0 dyn/cm led to significant deciliation events. The proteomic and bioinformatic analyses showed different ciliary protein profiles, distinct signaling pathways, and unique post-translational modification processes in the SCD mouse model. Consistent with the SCD mouse model results, our translational studies validated the enrichment of specific proteins, including Transferrin Receptor-1 (TfR1), Glyceraldehyde-3-Phosphate-Dehydrogenase (GAPDH), and ADP Ribosylation Factor Like GTPase-13B (ARL13B) in SCD patients. These findings underscore the clinical relevance of cilia in SCD and suggest that ciliary proteins are potential biomarkers for assessing vascular damage.
镰状细胞病(SCD)是一种遗传性血红蛋白病,其特征是红细胞(RBC)呈镰刀状。初级纤毛是机械感觉细胞器,突出于血管腔内以检测血流。我们之前报道过,微血管内皮细胞与镰状红细胞之间的相互作用导致血流改变,可提高活性氧水平,从而导致SCD患者的纤毛脱失增加。然而,在纤毛蛋白谱的背景下,镰状红细胞介导的纤毛脱失的影响仍不清楚。在这里,我们利用小鼠模型和人类参与者,研究了不同生理剪切应力强度下细胞纤毛的稳定性,并检查了SCD中的纤毛蛋白谱。我们的结果表明,在5.0达因/平方厘米的剪切应力下,使内皮纤毛暴露于镰状红细胞会导致显著的纤毛脱失事件。蛋白质组学和生物信息学分析显示,SCD小鼠模型中存在不同的纤毛蛋白谱、不同的信号通路和独特的翻译后修饰过程。与SCD小鼠模型结果一致,我们的转化研究验证了SCD患者中特定蛋白质的富集,包括转铁蛋白受体-1(TfR1)、甘油醛-3-磷酸脱氢酶(GAPDH)和ADP核糖基化因子样GTP酶-13B(ARL13B)。这些发现强调了纤毛在SCD中的临床相关性,并表明纤毛蛋白是评估血管损伤的潜在生物标志物。